Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.3.1.900
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Revenues    
Products $ 10,055,237 $ 8,625,034
Services 11,387,420 10,717,630
Total revenues 21,442,657 19,342,664
Cost of sales    
Products 7,137,149 6,347,583
Services 6,672,282 6,596,017
Total cost of sales 13,809,431 12,943,600
Gross profit 7,633,226 6,399,064
Operating expenses    
General and administrative 7,997,512 7,264,630
Selling 1,687,479 1,796,268
Research and development 591,585 1,041,483
Total operating expenses 10,276,576 10,102,381
Loss from operations (2,643,350) (3,703,317)
Other income (expense)    
Interest and other income 14,334 9,710
Interest expense (171,944) (177,345)
Total other income (expense) (157,610) (167,635)
Loss before income taxes   (3,870,952)
Consolidated net loss (2,800,960) (3,870,952)
Less: Loss attributable to the noncontrolling interest 73,547 125,140
Net loss attributable to Tecogen Inc. $ (2,727,413) $ (3,745,812)
Net loss per share - basic and diluted (usd per share) $ (0.16) $ (0.24)
Weighted average shares outstanding - basic and diluted (shares) 16,860,453 15,607,897